Tag: NASDAQ:AMZN
-
Cloudflare Skyrockets 26% Pre-Market; Expedia Plunges 14% After CEO Resignation, and More
Alphabet (NASDAQ:GOOGL) – Google has renamed its chatbot Bard to Gemini, powered by a new artificial intelligence. Consumers can pay $19.99/month for Gemini Advanced, which includes a more powerful AI model and two terabytes of cloud storage, competing with Microsoft (NASDAQ:MSFT). Amazon (NASDAQ:AMZN) – Amazon and BMW triumphed in an action against sellers of counterfeit…
-
Arm Achieves Record Revenue, PayPal Shares Plummet by More Than 9%, and Latest Updates
Apple (NASDAQ:AAPL) – According to The Information, Apple is working on prototypes for at least two foldable iPhone models that fold horizontally, resembling a clamshell. These foldable devices are in the early stages of development and are not expected for mass production until 2024 or 2025. Apple has recently contacted at least one manufacturer in…
-
Moody’s Downgrades NYCB to Junk Status, Ford Declares Special Dividend, and Other Market Updates
Moody’s (NYSE:MCO), New York Community Bancorp (NYSE:NYCB) – Moody’s downgraded the long-term and some short-term ratings of New York Community Bancorp to junk on Tuesday, with warnings of potential downgrades. The downgrade reflects high governance risks and potential sensitivity to confidence due to significant losses in commercial real estate loans. NYCB shares are down 9.76%…
-
Boeing Faces Strike Threat, Palantir Up 18% After Recording its First Profitable Year, and More
Boeing (NYSE:BA) – The FAA announced that 94% of Boeing 737 MAX 9 planes have returned to service after a suspension caused by an air emergency. The inspections included a detailed review, and investigations are ongoing. The FAA is reassessing its oversight of Boeing, considering possible changes in inspection approaches and relations with the manufacturer.…
-
Fading Rate Cut Optimism May Lead To Pullback On Wall Street
The major U.S. index futures are currently pointing to a modestly lower open on Monday, with stocks likely to give back ground following the rally seen to close out the previous week. Traders may look to cash in on the rally seen over the two previous sessions amid fading optimism about the likelihood the Federal…
-
US Index Futures Down, Oil Prices Slide – Market Responds to Powell’s Remarks Ahead of Opening Bell
U.S. index futures are down in Monday’s pre-market, reflecting the impact of Jerome Powell’s statements in a CBS interview on Sunday. The Fed chairman tempered expectations for immediate interest rate cuts, signaling a more cautious approach. This scenario precedes a week full of corporate earnings releases and comes in a context of geopolitical tensions in…
-
U.S. Stocks Extend Thursday’s Rally On Upbeat Meta, Amazon Results
Stocks moved sharply higher over the course of the trading day on Friday, extending the recovery rally seen during trading Thursday’s session. The major averages more than offset the steep drop seen on Wednesday, with the Dow and the S&P 500 reaching new record closing highs. The major averages pulled back off their best levels…
-
Amazon Surpasses Analyst Predictions with Stellar Q4 Performance, Stock Rises Over 7%
Amazon (NASDAQ:AMZN) showcased an exceptional performance in the fourth quarter after Thursday’s market close, exceeding analyst predictions and providing a solid outlook for the current quarter, leading to a stock rise of more than 7% in Friday morning’s trading. Amazon reported earnings of $1.00 per share, which exceeded the anticipated 80 cents per share forecasted…
-
Arcus Biosciences Stock Jumps 20% on $320M Gilead Investment, Super Micro Surpasses Forecasts, and More News
Arcus Biosciences (NYSE:RCUS), Gilead Sciences (NASDAQ:GILD) – Arcus Biosciences‘ shares rose 19.5% in pre-market trading on Tuesday following news of a $320 million investment by Gilead Sciences, which also led to a revision of their collaboration agreement. This change aims to boost the growth of their joint development programs and includes the appointment of Johanna…
-
Philips Shares Drop 6% as US Sales Halted Following Agreement on Faulty Sleep Apnea Devices, and latest news
Royal Philips NV (NYSE:PHG) – Royal Philips NV has suspended sales of sleep apnea devices and ventilators in the US after reaching an agreement with the US Food and Drug Administration due to quality issues. Philips has set aside 363 million euros in the fourth quarter to cover the costs of the agreement. The company…